FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

  Рет қаралды 7,136

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
Preclinical Considerations for Cell and Gene Therapy Products, an FDA Perspective
46:52
U.S. Food and Drug Administration
Рет қаралды 17 М.
CMC Considerations for CAR T Cell Product Development
29:42
U.S. Food and Drug Administration
Рет қаралды 12 М.
Непосредственно Каха: сумка
0:53
К-Media
Рет қаралды 12 МЛН
Designing First-In-Human Trials for Small Molecules and Biologics
37:34
U.S. Food and Drug Administration
Рет қаралды 11 М.
FDA Oncology Drug Development Overview - Past to Present
29:20
U.S. Food and Drug Administration
Рет қаралды 4,2 М.
Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine
37:46
U.S. Food and Drug Administration
Рет қаралды 3,3 М.
FDA Clinical Investigator Training Course (CITC) 2022, Day 1 - Part 3
1:10:23
U.S. Food and Drug Administration
Рет қаралды 3,1 М.
FDA Regulatory Requirements for Clinical Investigators and Case Examples (9of14) REdI 2018
41:00
U.S. Food and Drug Administration
Рет қаралды 4,2 М.
Overview of Non-clinical Assessment in Drug Development (8/14) REdI 2017
54:28
U.S. Food and Drug Administration
Рет қаралды 16 М.
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
1:20:20
FDA Clinical Investigator Training Course (CITC) 2024 - Day Two - Session Two
2:23:52
U.S. Food and Drug Administration
Рет қаралды 555
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session One
2:14:51
U.S. Food and Drug Administration
Рет қаралды 879
New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment (1 of 2)
2:19:09